Clinical trials: Gingival Squamous Cell Carcinoma

Upper Gingival Squamous Cell Carcinoma

Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms

• Completed
• Age: 18 years and older
• Observational study
• Results posted

Hypothesis: Cetuximab, an anti-EGFR antibody, is used with radiotherapy in the treatment of locally advanced and inoperable upper aerodigestive tract cancers.

Trial name

FCR-VADS (NCT01827956)

Testing

Cetuximab

Where

France

Volunteers

121 people

Sponsor

Institut Bergonié